Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Debbie Hicks

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
Orphanet Journal of Rare Diseases|September 8, 2017
Exome sequences versus sequential gene testing in the UK highly specialised Service for Limb Girdle Muscular DystrophyElizabeth Harris, Ana Topf, Rita Barresi, et al.
Neuro-Oncology|October 8, 2024
Molecular and clinical heterogeneity within MYC-family amplified medulloblastoma is associated with survival outcomes: A multicenter cohort studyEdward C Schwalbe, Janet C Lindsey, Marina Danilenko, et al.
Acta Neuropathologica|July 13, 2022
Single-cell DNA sequencing identifies risk-associated clonal complexity and evolutionary trajectories in childhood medulloblastoma developmentMarina Danilenko, Masood Zaka, Claire Keeling, et al.
Neuropathology and Applied Neurobiology|April 7, 2021
Advanced molecular pathology for rare tumours: A national feasibility study and model for centralised medulloblastoma diagnosticsStephen Crosier, Debbie Hicks, Edward C Schwalbe, et al.
The Lancet. Child & Adolescent Health|November 23, 2020
Time, pattern, and outcome of medulloblastoma relapse and their association with tumour biology at diagnosis and therapy: a multicentre cohort studyRebecca M Hill, Stacey Richardson, Edward C Schwalbe, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|March 21, 2022
The Place and Value of Sodium-Glucose Cotransporter 2 Inhibitors in the Evolving Treatment Paradigm for Type 2 Diabetes Mellitus: A Narrative ReviewJohn P H Wilding, Marc Evans, Kevin Fernando, et al.
Cell Reports|August 4, 2022
Medulloblastoma group 3 and 4 tumors comprise a clinically and biologically significant expression continuum reflecting human cerebellar developmentDaniel Williamson, Edward C Schwalbe, Debbie Hicks, et al.
Brain : a Journal of Neurology|February 14, 2013
Congenital myasthenic syndromes due to mutations in ALG2 and ALG14Judith Cossins, Katsiaryna Belaya, Debbie Hicks, et al.
The Lancet. Oncology|May 27, 2017
Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort studyEdward C Schwalbe, Janet C Lindsey, Sirintra Nakjang, et al.
Human Molecular Genetics|December 17, 2013
Recessive and dominant mutations in COL12A1 cause a novel EDS/myopathy overlap syndrome in humans and miceYaqun Zou, Daniela Zwolanek, Yayoi Izu, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Orphanet Journal of Rare Diseases|September 8, 2017
Exome sequences versus sequential gene testing in the UK highly specialised Service for Limb Girdle Muscular DystrophyElizabeth Harris, Ana Topf, Rita Barresi, et al.
Neuro-Oncology|October 8, 2024
Molecular and clinical heterogeneity within MYC-family amplified medulloblastoma is associated with survival outcomes: A multicenter cohort studyEdward C Schwalbe, Janet C Lindsey, Marina Danilenko, et al.
Acta Neuropathologica|July 13, 2022
Single-cell DNA sequencing identifies risk-associated clonal complexity and evolutionary trajectories in childhood medulloblastoma developmentMarina Danilenko, Masood Zaka, Claire Keeling, et al.
Neuropathology and Applied Neurobiology|April 7, 2021
Advanced molecular pathology for rare tumours: A national feasibility study and model for centralised medulloblastoma diagnosticsStephen Crosier, Debbie Hicks, Edward C Schwalbe, et al.
The Lancet. Child & Adolescent Health|November 23, 2020
Time, pattern, and outcome of medulloblastoma relapse and their association with tumour biology at diagnosis and therapy: a multicentre cohort studyRebecca M Hill, Stacey Richardson, Edward C Schwalbe, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|March 21, 2022
The Place and Value of Sodium-Glucose Cotransporter 2 Inhibitors in the Evolving Treatment Paradigm for Type 2 Diabetes Mellitus: A Narrative ReviewJohn P H Wilding, Marc Evans, Kevin Fernando, et al.
Cell Reports|August 4, 2022
Medulloblastoma group 3 and 4 tumors comprise a clinically and biologically significant expression continuum reflecting human cerebellar developmentDaniel Williamson, Edward C Schwalbe, Debbie Hicks, et al.
Brain : a Journal of Neurology|February 14, 2013
Congenital myasthenic syndromes due to mutations in ALG2 and ALG14Judith Cossins, Katsiaryna Belaya, Debbie Hicks, et al.
The Lancet. Oncology|May 27, 2017
Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort studyEdward C Schwalbe, Janet C Lindsey, Sirintra Nakjang, et al.
Human Molecular Genetics|December 17, 2013
Recessive and dominant mutations in COL12A1 cause a novel EDS/myopathy overlap syndrome in humans and miceYaqun Zou, Daniela Zwolanek, Yayoi Izu, et al.
Pageof 6